Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pumpkinseed has developed a novel proteomics platform that combines nanotechnology, biochemistry, silicon photonics, and machine learning to enable high-throughput, label-free quantification and sequencing of proteins. The company’s approach allows rapid extraction of vibrational “fingerprints” from protein molecules without biochemical probes or labels. This could transform cellular biology research and open new avenues in diagnostics and therapeutics by providing unprecedented insight into the proteome[1][3][5]. Early applications also include sensitive pathogen detection assays for food safety[6].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pumpkinseed.